Microzide (hydrochlorothiazide)

Company: Watson Pharmaceuticals
Approval Status: Approved January 1997
Treatment for: mild-to moderate hypertension
Areas: Cardiovascular / Cardiology; Diabetes / Endocrinology

| General Information |

General Information

Microzide has been approved for the treatment of mild-to moderate hypertension.

< back to top

Microzide Drug Information

The Microzide drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.